IDHQ - ETF AI Analysis
Top Page
Invesco S&P International Developed High Quality ETF (IDHQ)
IDHQ, the Invesco S&P International Developed High Quality ETF, earns its rating mainly because it holds several financially strong, globally established companies like Novartis, ASML, Nestlé, and Sony, which bring solid profitability, cash flow, and generally positive outlooks to the portfolio. The rating is held back somewhat by holdings where valuation looks expensive or momentum is weak, such as SAP, Allianz, and others with signs of overvaluation or bearish technical trends. A key risk factor is that many top positions share similar valuation concerns and technical warning signs, which could increase volatility if market conditions turn against these types of stocks.
IDHQ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.22B
- Region
- Developed Markets
- Expense Ratio
- 0.29%
- Beta
- 0.80
- Issuer
- Invesco
- Inception Date
- Jun 13, 2007
- Dividend Yield
- 1.89%
- Asset Class
- Equity
- Index Tracked
- S&P Quality Developed Ex-U.S. LargeMidCap Index
IDHQ Summary
The Invesco S&P International Developed High Quality ETF (IDHQ) tracks the S&P Quality Developed Ex-U.S. LargeMidCap Index, focusing on strong, established companies in developed countries outside the United States. It holds well-known names like Nestlé, Novartis, Roche, ASML, and Sony, spread across many sectors such as healthcare, technology, and consumer goods. Someone might invest in IDHQ to diversify beyond the U.S. and seek long-term growth from high-quality international companies. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?
This ETF has an expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 you invest. That’s a bit higher than the cheapest index ETFs because it tracks a more specialized “high quality” international index rather than a plain broad-market index.
What would affect this ETF?
IDHQ could benefit if developed markets outside the U.S. grow steadily, especially in sectors like health care, technology, and consumer staples where top holdings such as Roche, ASML, Novartis, and Nestlé may gain from innovation and stable consumer demand. On the other hand, global slowdowns, stronger local regulations, currency swings, or rising interest rates that pressure international stocks and financial companies like Allianz and industrial names like Rolls-Royce could weigh on the ETF’s future performance.
IDHQ Top 10 Holdings
IDHQ leans heavily on European health care and consumer staples, with Roche and Novartis providing a steady, rising backbone for the fund. Nestlé adds defensive flavor, though its mixed, recently lagging performance has been a mild drag. On the growth side, ASML and Japan’s Advantest are key semiconductor engines, with strong longer-term momentum despite some recent choppiness. Recruit Holdings and Sony round out the Japan exposure, both trending higher and giving the ETF a global developed-markets tilt outside the U.S., without being overly tied to any single name.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 4.72% | $58.80M | CHF 240.72B | 32.30% | 80Outperform |
 NL:ASML | ASML Holding NV | 4.11% | $51.11M | EUR 529.05B | 45.71% | 76Outperform |
 CH:NESN | Nestlé SA | 3.66% | $45.49M | CHF 217.12B | 8.87% | 71Outperform |
 DE:SAP | SAP SE | 3.19% | $39.73M | EUR 241.28B | -5.20% | 66Neutral |
 JP:6857 | Advantest | 2.51% | $31.17M | JPY 24.95T | 58.72% | 75Outperform |
 JP:6098 | Recruit Holdings Co | 2.49% | $30.94M | JPY 24.91T | 138.97% | 67Neutral |
 DE:ALV | Allianz | 2.46% | $30.61M | EUR 166.97B | 29.56% | 67Neutral |
 GB:RR | Rolls-Royce Holdings | 2.36% | $29.32M | GBP 104.24B | 10.05% | 71Outperform |
 JP:6758 | Sony | 2.19% | $27.24M | JPY 23.50T | -8.43% | 73Outperform |
IDHQ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDHQ, the sentiment is Positive. The current price of 45.04 is above the 20-day moving average (MA) of 43.96, above the 50-day MA of 44.06, and above the 200-day MA of 40.98, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 62.67 is Neutral, neither overbought nor oversold. The STOCH value of 73.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDHQ.
IDHQ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| IDHQ | $45.04 | $48.00(6.57% Upside) | $1.22B | 0.29% | 67Neutral |
 LVHI | $43.72 | $47.73(9.17% Upside) | $6.39B | 0.40% | 67Neutral |
 GSIE | $47.32 | $57.56(21.63% Upside) | $5.93B | 0.25% | 65Neutral |
 IMTM | $51.24 | $67.12(30.99% Upside) | $4.14B | 0.30% | 69Neutral |
 IDMO | $58.55 | $74.64(27.48% Upside) | $4.12B | 0.25% | 71Outperform |
 INTF | $42.07 | $50.89(20.97% Upside) | $3.69B | 0.16% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IDHQ | Invesco S&P International Developed High Quality ETF | 45.04 | 11.50 | 34.28% | |
| LVHI | Legg Mason International Low Volatility High Dividend ETF | 43.72 | 9.50 | 27.75% | |
| GSIE | Goldman Sachs ActiveBeta International Equity ETF | 47.32 | 7.15 | 17.80% | |
| IMTM | iShares MSCI Intl Momentum Factor ETF | 51.24 | 5.59 | 12.25% | |
| IDMO | Invesco S&P International Developed Momentum ETF | 58.55 | 6.80 | 13.15% | |
| INTF | iShares MSCI Intl Multifactor ETF | 42.06 | 6.85 | 19.46% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.